Strain Data Sheet
RBRC01269
Strain Information | |
|---|---|
| Image | |
| BRC No. | RBRC01269 |
| Type | Targeted Mutation |
| Species | Mus musculus |
| Strain name | B6;129(Cg)-Gnptab<tm1.1Zili>/SiecRbrc |
| Former Common name | Stealth [lacZ/+] |
| H-2 Haplotype | |
| ES Cell line | |
| Background strain | |
| Appearance | |
| Strain development | Targeting of Stealth：2001, Denis-Luc Ardiet, ISREC |
| Strain description | Mice with a lacZ knock-in in the first major coding exon of Stealth. The lacZ ORF begins with the first start codon of that stealth exon. The loxP flanked neoR cassette was removed with help of a Cre deleter mouse of unknown hybrid genetic background.Purpose of that mouse strain is to analyze stealth function in mice, in particular for its role in development, innate immunity, and homeostasis of organ systems. |
| Colony maintenance | This allele has been progressively backcrossed into a C57BL/6J (Harlan) background. The more prominent the C57BL/6J contribution became the more ataxic the more short lived mice homozygous for Stealth lacZ became. Beginning with the 4th backcross, the homozygotes died at birth or during the days before weaning. |
| References | |
Health Report | |
|---|---|
| Examination Date / Room / Rack | |
Gene | |
|---|---|
| Gene info | Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter GnptabN-acetylglucosamine-1-phosphate transferase, alpha and beta subunits10Gnptab<tm1.1Zili>targeted mutation 1.1, Olav Zilian Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter lacZbeta-galactosidase (E. coli)10 Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter loxPphage P1 loxP10loxP |
Ordering Information | |
|---|---|
| 供与核酸 | E. coli lacZ, phage P1 loxP site, SV40-3' UTR, mouse stealth genomic DNA |
| Research application | Cell Biology Research Cre/loxP system Developmental Biology Research Fluorescent Proteins/lacZ System Immunology and Inflammation Research |
| 提供条件 | 条件を付加する。利用者は事前に寄託者の提供承諾書を得る。 研究成果の公表にあたって寄託者の指定する文献を引用する。To be cited is any publication by the DEPOSITOR describing the BIOLOGICAL RESOURCE for the first time. This term is to be respected in particular when the first 2 years after deposition of the BIOLOGICAL RESOURCE are passed. 研究成果の公表にあたって謝辞の表明を必要とする。This term is to be respected in particular when the material was requested after the first 2 years upon deposition of the BIOLOGICAL RESOURCE. 1) The RECIPIENT agrees to use this BIOLOGICAL RESOURCE as a collaboration with the DEPOSITOR. Furthermore, the RECIPIENT agrees to include the DEPOSITOR as a co-author in any publications resulted by the use of the BIOLOGICAL RESOURCE in research projects initiated during the first 2 years after deposition by the DEPOSITOR to the RIKEN BRC. 2) Further, the RECIPIENT must inform the DEPOSITOR about the research project using the BIOLOGICAL RESOURCE and must obtain a prior permission from the DEPOSITOR to avoid the conflict of interest with the DEPOSITOR. 3) Furthermore, prior to filing an application for a patent, or intellectual property or other rights based on the results of research using the BIOLOGICAL RESOURCE, the RECIPIENT shall acquire the consent from the DEPOSITOR for such application. |
| Depositor | Olav Zilian（Institut Suisse de Recherche Experimentale sur le Cancer (ISREC)） |
| Strain Status |  凍結胚 凍結精子 |
| Strain Availability | 凍結胚より作出したマウスを2~4ヶ月以内に提供可能 凍結精子を1ヶ月以内に提供可能 凍結胚を1ヶ月以内に提供可能 |
| Additional Info. | Necessary documents for ordering: |
BRC mice in Publications |
|---|
| No Data |